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Abstract
Background: High-quality cancer information resources are available but underutilized by the public. Despite greater
awareness of the National Cancer Institute's Cancer Information Service among low-income African Americans and
Hispanics compared with Caucasians, actual Cancer Information Service usage is lower than expected, paralleling excess
cancer-related morbidity and mortality for these subgroups. The proposed research examines how to connect the
Cancer Information Service to low-income African-American and Hispanic women and their health care providers. The
study will examine whether targeted physician mailing to women scheduled for colposcopy to follow up an abnormal Pap
test can increase calls to the Cancer Information Service, enhance appropriate medical follow-up, and improve
satisfaction with provider-patient communication.
Methods/Design: The study will be conducted in two clinics in ethnically diverse low-income communities in Chicago.
During the formative phase, patients and providers will provide input regarding materials planned for use in the
experimental phase of the study. The experimental phase will use a two-group prospective randomized controlled trial
design. African American and Hispanic women with an abnormal Pap test will be randomized to Usual Care (routine
colposcopy reminder letter) or Intervention (reminder plus provider recommendation to call the Cancer Information
Service and sample questions to ask). Primary outcomes will be: 1) calls to the Cancer Information Service; 2) timely
medical follow-up, operationalized by whether the patient keeps her colposcopy appointment within six months of the
abnormal Pap; and 3) patient satisfaction with provider-patient communication at follow-up.
Discussion: The study examines the effectiveness of a feasible, sustainable, and culturally sensitive strategy to increase
awareness and use of the Cancer Information Service among an underserved population. The goal of linking a public
service (the Cancer Information Service) with real-life settings of practice (the clinics), and considering input from
patients, providers, and Cancer Information Service staff, is to ensure that the intervention, if proven effective, can be
incorporated into existing care systems and sustained. The approach to study design and planning is aimed at bridging
the gap between research and practice/service.
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Background
The burden of cancer falls most heavily on poor ethnic
minorities - particularly African Americans and Hispanics
[1]. Overcoming such disparities requires finding effective
ways to increase the use and impact of scientifically accu-
rate cancer information. Excellent, free resources, such as
the National Cancer Institute's Cancer Information Serv-
ice (CIS) exist and have potential to transmit needed
information to underserved groups. However, despite
greater awareness of the CIS by low-income African Amer-
ican and Hispanic adults, actual CIS usage is lower than
expected, paralleling excess cancer-related morbidity and
mortality for these subgroups [2]. The planned study will
examine the efficacy of a targeted physician mailing
designed to connect the CIS to low-income African Amer-
ican and Hispanic women who need cancer-related infor-
mation due to a scheduled colposcopy to follow up an
abnormal Pap test.
Cancer Information Service
Established in 1975, the CIS is a health communication
service designed to help meet the cancer information
needs of the general public, health professionals, cancer
patients, and their family members and friends [3]. Most
users access the CIS via a telephone number (1-800-4-
CANCER) and are connected to English- or Spanish-
speaking information specialists. Information specialists
are highly trained in both informational and the interper-
sonal aspects of cancer communication and are adept at
addressing a wide range of cancer inquiries, including can-
cer prevention and control [2]. The CIS Partnership Pro-
gram, dedicated to addressing cancer health disparities,
works with partner organizations that have an estab-
lished, trusted presence in the community. The CIS
Research Program seeks to advance cancer related health
communication science by designing, implementing, and
disseminating results of innovative studies in a manner
that bridges the gap between cancer research and service
[4].
Awareness data from the 2003 National Health Informa-
tion National Trends Survey suggest that the CIS is reach-
ing the underserved. Awareness of the CIS was greater
among minorities (51% of Hispanics, 45% of African
Americans) than Whites (28%), contrasting with the
opposite demographic awareness pattern for NCI, NIH,
and ACS. Also, CIS awareness increased as income and
education decreased and was greater among those with-
out health insurance than those with it [2]. However,
awareness data contrasted markedly with actual usage
data showing that more Whites (83%) than African Amer-
icans (13.4%) or Hispanics (2%) called the service. These
findings suggest barriers to use of the CIS by underserved
minorities, despite good awareness.
The planned research stems from three premises. First, a
strategic partnership between health care providers and
the CIS can overcome call barriers and be advantageous to
patients and providers [2,5]. Second, the CIS is ideally
positioned to reach and meet the cancer information
needs of the underserved, many of whom have telephone
but no internet access. Third, the CIS can play an impor-
tant role in overcoming communication barriers that con-
tribute to cancer health disparities. Because the CIS
enables continuous access to valid cancer-relevant infor-
mation in the context of human interaction, implement-
ing a strategic partnership between patients, CIS, and
providers is consistent with the Institute of Medicine's call
for care based on continuous healing relationships [6].
CIS offers a bridge between the underserved patients' pre-
ferred interpersonal source (the provider) and informa-
tion that is available from family and friends in a low
literacy community [7,8]. As such, CIS has the potential to
positively impact multiple levels in an ecological model
of public health communication [9,10].
Effective public health communication
From an ecological perspective [9,10], disparities are
grounded in a system of reciprocal influences at the
intrapersonal, group, community, institutional, and pop-
ulation levels that impede optimal awareness, under-
standing, decision-making, and action about health.
Effective public health communication interventions acti-
vate multiple channels to impact the different levels in the
ecological framework [11]. Moreover, effective health
communication initiatives make their outreach relevant
to the intended audience [12]. The need to adopt an audi-
ence-centered perspective is especially strong when trying
to connect with racial and ethnic minorities. Intraper-
sonal issues to be considered when making outreach to
low-income African Americans and Hispanics include lan-
guage and attitudinal barriers, low health literacy, lack of
information, and misinformation about cancer screening,
risk, and treatment [13-16].
Two widely used modes of audience-centric outreach are
targeting and tailoring. Targeting, which utilizes a market
segmentation approach, creates messages to reach a spe-
cific population segment or group, often defined by
shared demographics like ethnicity or language. Targeting
of physician mailing in the proposed research will be per-
formed on the basis of medical condition, clinic/ethnicity,
and language. Of necessity, targeting addresses only sur-
face, observable characteristics [17]. Tailoring, in contrast,
creates messages to reach a specific individual whose char-
acteristics are determined by assessment. Because a
skilled, non-time-constrained human can tailor messages
much more effectively than a computer [18], CIS informa-
tion specialists highly trained in interpersonal communi-
cation will be the tailoring agents for this study.BMC Public Health 2009, 9:444 http://www.biomedcentral.com/1471-2458/9/444
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At an interpersonal level, the underserved express a strong
cultural preference for receiving health information ver-
bally [14,19] and primarily from health care providers
[20-22]. In the current health care environment, those
preferences increase informational dependence on over-
burdened providers who are accurately perceived by
patients as lacking time for discussion [23]. Augmenting
the communication challenges, providers spend less time
with the underserved [24], at least partly because low lit-
eracy patients ask few questions of medical professionals
even when language barriers are not an issue [19,25,26].
There is a tendency for both underserved patients and
their providers to emerge from the medical encounter dis-
satisfied, and with patients feeling that their information
needs have not been adequately addressed [27,28]. By vir-
tue of the CIS's availability to the public, and the diverse
and well-trained staff [29], information specialists poten-
tially offer a vital resource to bridge this gap between
underserved patients and their health care providers.
Sustainability
Innovations at the institutional level occur most often
when a recognized need and the means to resolve it
emerge in tandem [30]. Such systems can be described as
balancing "need-pull" with "technology-push". The time
constraints of providers and unmet informational needs
of low literacy patients represent a strong need that can be
served by available CIS technology. A simple "push" in
the planned intervention is the provider letter that alerts
the patient to a medical risk and an information need.
Explaining that the CIS call is to be discussed at the
upcoming medical appointment frames the CIS in a cul-
turally acceptable normative context as a provider-
extender rather than an outsider. Patients who are acti-
vated to discuss CIS calls at the medical visit give a recip-
rocal "push" that helps educate providers. By suggesting
questions to ask of the CIS, the intervention prompts
patients to learn about information gathering behavior,
creating communication skills that may generalize to the
medical encounter. The intervention is sustainable as a
part of institutionalized office practice [31,32].
To maximize public health impact, the CIS needs to reach
large new populations of underserved individuals whose
cancer information needs are presently unmet [33]. The
population at risk for cancer represents a good target
because it is larger than the population of those already
diagnosed with cancer. Thus, the planned intervention
has potential to be sustained and increase CIS impact
among the underserved.
Cervical Cancer Disparities
African American women have both increased incidence
and the highest rate of mortality from cervical cancer,
showing mortality rates more than twice that of non-His-
panic Whites [34]. Survival is also lower among Hispan-
ics, largely because of more advanced cancer at the time of
diagnosis [1]. As many as 50% of medically underserved
women in the National Breast and Cervical Cancer Early
Detection Program failed to receive appropriate follow-up
for an abnormal Pap smear, with the likelihood of no fol-
low-up being greatest for African American women [35].
Another recent study of the urban poor found an inade-
quate follow-up rate of 38%, despite opportunities for fol-
low-up since 86% of women continued to receive care in
the same place [36].
Misinformation, lack of information, fear, and embarrass-
ment are all barriers to receiving adequate follow-up care.
Predictors of good follow-up are remembering receiving a
letter from the provider, knowing the Pap result, being
able to report the result correctly, understanding the pur-
pose of colposcopy, having low fear of pain, and feeling
confident that the provider will understand the patient's
needs [37,38]. Consistent with the health belief model
[39], therefore, accurately perceiving one's susceptibility
to cervical cancer, feeling confident about being able to
take protective action, and perceiving prognostic benefits
(versus fatalism) of follow-up for early detection are asso-
ciated with better follow-up. Telephone outreach address-
ing these domains has been demonstrated to be effective
in increasing follow-up adherence to colposcopy by low-
income, inner-city women [40]. An innovation in the pro-
posed research is that telephone support will be provided
by CIS information specialists.
Study Aims
Using formative and experimental research methodolo-
gies, the planned research will investigate how to connect
the CIS to low-income urban African-American and His-
panic women with abnormal PAP tests. Specific aims are
to examine whether a targeted physician mailing can
increase calls to the CIS, enhance appropriate medical fol-
low-up, and improve satisfaction with provider-patient
communication at the follow-up medical visit.
Methods/Design
Study sites and phases
Study procedures were reviewed and approved by North-
western University's Office for the Protection of Research
Subjects Institutional Review Board. The research will be
conducted in two large community clinics that serve poor,
ethnically diverse communities in Chicago. At the Erie
Family Health Center (EFHC) on Chicago's West side,
82% of clients live at or below the federal poverty level;
57% have no health insurance; 90% are Hispanic or Lat-
ino. At Prentice Ambulatory Clinic (PAC) on Northwest-
ern's Chicago campus, outpatient services are provided to
a population that is 90% Medicaid/Medicare and 85%
minority (60% African American, 30% Hispanic).BMC Public Health 2009, 9:444 http://www.biomedcentral.com/1471-2458/9/444
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The initial, formative phase of the research will solicit
input from patients and providers regarding all materials
planned for use in the experimental phase of the study
(e.g. questionnaires, consent procedures, and interven-
tion materials). The experimental phase will follow com-
paring the intervention and control conditions.
Formative phase
The formative research phase will acquaint the project
team with the clinics. Next, focus groups with patient and
providers will be conducted in each of these clinics.
Participants
Participants for the formative phase will be selected to be
representative of the population at each clinic. Inclusion
criteria for patients will be women over the age of 18 years
who have had a pap test in these two clinics and who
agree to participate. Inclusion criteria for providers will be
any provider who administers pap tests and conducts col-
poscopy testing for women at the two clinics and are avail-
able to participate. Patients and providers will be
consented prior to conducting the focus groups.
Focus groups
The project staff will conduct 4 focus groups of 5 partici-
pants each: 5 patients from EFHC, 5 providers from
EFHC, 5 patients from PAC, and 5 providers from PAC.
The patient focus group at EFHC will be co-facilitated by
staff that is fluent in Spanish. Topics to be discussed in the
focus groups are: a) perceived information support needs
and barriers to following up abnormal Pap tests (e.g.,
fears, embarrassment, misinformation, kinds of informa-
tion and messages desired, kinds of messages deemed
unhelpful), b) feedback on the letters and assessment
instruments planned for the randomized controlled trial
(RCT) (e.g., reactions to calling the CIS service, reactions
to inclusion of the word 'cancer' in the name of a service
offering preventive care), c) familiarity with and views
about the CIS, d) barriers and facilitators to telephoning
the CIS for information about cancer prevention and
screening. Focus groups will be audio taped to ensure the
discussions are completely and accurately recorded.
Analysis
Focus group data will be transcribed verbatim by project
staff. Staff fluent in Spanish will translate the Spanish
focus groups in English and then transcribe them. Tran-
scribed data from focus groups will be analyzed and inter-
preted via thematic analysis [41]. Three raters will read the
transcribed materials thoroughly to identify themes for
each topic. Codes for these themes will be developed and
the responses will be tabulated using the coding scheme.
Lessons learned will be discussed and will help guide tai-
loring the letter and assessment instrument for the RCT.
Experimental phase
Study Design
The experimental phase of the study will be conducted
using a two-group prospective RCT design comparing the
effects of two provider mailing conditions: control (Usual
Care) versus intervention (CIS + Questions). The RCT
design will be 2 × 2 factorial with Clinic (EFHC versus
PAC) and Letter (Usual Care versus Intervention) as
between subjects factors.
Participants
This study aims to recruit 500 women with an abnormal
annual Pap test and follow-up scheduling for colposcopy
at EFHC or PAC. Based on the current patient flow in the
two clinics, we expect to randomize approximately 100
women from EFHC and 400 from PAC. Entry criteria will
include women of age 18 or older who speak either Eng-
lish or Spanish and who have received an annual Pap test
that warrants scheduling for colposcopy at EFHC or PAC.
Women scheduled for a repeated Pap test or repeated col-
poscopy as follow up to a previous abnormality will not
be enrolled because they may already have completed
their initial information seeking process.
Randomization
Patients will be randomized to two conditions that
involve different letters from the provider. Usual Care par-
ticipants will receive a generic letter reminding them of
their follow-up appointment. Intervention  participants
will receive a targeted letter reminding them of the follow-
up appointment, asking them or someone they designate
to call CIS, and suggesting some questions to ask.
The patient will be the unit of randomization and the
project statistician will prepare and manage the randomi-
zation scheme. Separate randomizations will be per-
formed for EFHC and for PAC. Usual Care and
Intervention letters will be placed in envelopes. At the
time randomization envelopes are selected, group alloca-
tion will be concealed from study staff and clinic staff so
that there is no selection bias in the randomization proc-
ess.
Intervention
As soon as the patient has received notification of the lab
Pap test result and has been scheduled for a colposcopy
appointment, the appropriate control or intervention let-
ter from the provider will be sent, along with a letter
informing the patient about the study. The Usual Care let-
ter from the provider will confirm the abnormal Pap and
remind the patient of the scheduled follow-up appoint-
ment for colposcopy. The Intervention (CIS + Questions)
letter from the provider will convey the same appoint-
ment information as the Usual Care letter. It will, in addi-
tion, ask the patient or a designate to telephone 1-800-4-BMC Public Health 2009, 9:444 http://www.biomedcentral.com/1471-2458/9/444
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CANCER and it will suggest some questions to ask about
abnormal Pap tests and colposcopy. The suggested ques-
tions are: "What does an abnormal Pap test mean?",
"What is colposcopy and what can I expect during colpos-
copy?", and "How will it benefit me to take the test?"
Consistent with the Institute of Medicine's [42] recom-
mendation, the letters will be appropriate for reading
skills at or below an eighth-grade level. The Lexile, a meas-
ure of reading difficulty, will be used to gauge reading
level [43,44].
Letters will be written in the patient's primary language,
Spanish or English. They will be mailed on PAC or EFHC
letterhead with a signature per the patient's provider. Text
will be typed double-spaced in large font, filling less than
a page. Like all materials planned for use in the RCT, the
proposed letters will be reviewed with community mem-
bers and providers during the initial formative phase of
the study. The final content of the Usual Care and Inter-
vention letters will be based on input from patients and
providers.
Outcomes and measures
Primary outcomes
There are three primary study outcomes 1) telephone calls
to CIS (call volume); 2) timely completion of medical fol-
low-up (within 6 months); 3) patient satisfaction with
doctor-patient communication at medical follow-up.
Telephone calls to the CIS
The CIS will tabulate calls originating from the study.
When CIS information specialists answer the telephone,
they log call and caller information into a standard Elec-
tronic Call Record Form (ECRF). With the caller's consent,
three customer service questions are asked of all callers:
1. Have you used our service before?
2. How did you find our number to call?
3. What is your home ZIP code?
The ECRF response field for Question #2, "How Found
Out" (HFO) has many codes, e.g., 300 - TV, 400 - radio,
801- ACS etc., including blank codes that can be assigned
to a specific promotion or research study. Four How
Found Out response codes will be allocated to identify the
conditions in this study: Code 1: PAC, Usual Care; Code
2: PAC, Intervention; Code 3: EFHC, Usual Care; Code 4:
EFHC, Intervention.
Information specialists will follow a series of steps (see:
ECRF programming below) to determine which, if any, of
the four codes should be assigned to a call.
Operationalizing call tracking in this way produces de-
identified data. Consequently, it will not be possible to
link ECRF-coded call data to the patient's other individual
level outcome data. To accomplish such linking, self-
reported data on calls to CIS also will be collected from
identified participants during the exit interview. This will
allow exploratory examination of whether calling the CIS
appears to mediate more timely follow-up and improved
provider-patient interaction.
Timely medical follow-up
Scheduling of colposcopy appointments will be tracked
electronically and by exit interview. Timely medical fol-
low-up will be operationalized by whether the patient
keeps an appointment for colposcopy within six months
of the initial abnormal Pap. Colposcopy is the primary
disposition for abnormal Pap tests at EFHS and PAC.
Clinic staff endeavor to schedule all patients within three
months of the abnormal Pap. Colposcopy is performed
on-site at both EFHS and PAC, in order to maximize con-
tinuity and follow-up. The procedure may be performed
by the patient's primary care physician or by one of several
doctors at each clinic who specialize in colposcopy.
Patient satisfaction with provider-patient communication
Satisfaction with provider-patient communication will be
assessed by the Doctors Who Communicate Well scale from
the 2.0 Adult Core Survey of the Agency for Healthcare
Research and Quality's Consumer Assessment of Health
Plans Study (CAHPS®) [45-47]. The CAHPS scale consists
of four items asking the degree to which the provider: lis-
tens carefully, explains things understandably, shows
respect, and spends enough time with the patient. Each
item has 5 response options: never, sometimes, usually,
always, I didn't see the provider. The scale's developers
recommend collapsing responses to a 3-category distribu-
tion by combining "never" and "sometimes" into a single
category [48] yielding a 1-3 range per item, where higher
numbers indicate better care. Validated in both English
and Spanish [45-47], the Doctors Who Communicate Well
scale shows excellent internal consistency (Chronbach's
alpha = .86) and predicts the rated quality of health care
[45]. Patients will complete the CAHPS immediately after
the follow-up visit for colposcopy.
Ancillary outcomes
To support exploratory analyses, patients and providers
will be asked several additional questions at the medical
follow-up visit.
Patient exit interview
After completing the CAHPS, patients will be asked: 1)
whether they telephoned the CIS, and if so, how many
times; 2) whether any others telephoned the CIS on their
behalf, and, if so whom; 3) their satisfaction with the CISBMC Public Health 2009, 9:444 http://www.biomedcentral.com/1471-2458/9/444
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call experience; 4) other ways in which they sought infor-
mation about screening; 5) whether the doctor who per-
formed the colposcopy was their regular physician; 6)
whether family members accompanied them to the visit.
Provider exit interview
Because there is, to our knowledge, no existing short scale
to measure a patient's skill in communicating with pro-
viders, we developed a checklist of patient communica-
tion behaviors modeled after the SEGUE Framework [49].
The SEGUE checklist of provider communication tasks is
the most widely used tool for physician communication
training in North America. The six items to be rated Yes/
No are:
No Yes
A) Showed some understanding of Pap/colposcopy
B) Paid attention to what you said
C) Asked 1+ questions
D) Talked about concerns
E) Expressed interest in caring for her health
F) Used time efficiently
*Language barrier and no interpreter
Maintenance
Six months after project staff has discontinued the initia-
tive to randomize patients, clinic staff will be interviewed
to determine whether either clinic has continued to use
the tailored mailing.
Procedure and data collection
Protocol sequence
Clinic staff at both clinics will monitor Pap test results to
identify patients eligible for this study. Based on patient
flow data, we expect to be able to randomize approxi-
mately 100 women from EFHC and 400 women from
PAC. Participants will be randomized to two conditions
in which they will receive one of two letters previously
described: Usual Care participants will receive the general
reminder letter about their colposcopy appointment and
Intervention participants will receive the reminder letter,
plus a request to call the Cancer Information Service (1-
800-4-CANCER) and suggested questions to ask.
An in-person informed consent process will be under-
taken at the colposcopy appointment. Upon arrival for
the appointment, clinic staff will remind patients about
the letter, inform them about the study, and ask if they are
interested in further information. Those interested in fur-
ther information will be approached by research staff and
given a detailed description of the study, emphasizing that
participation is completely voluntary. Participants who
agree to participate and provide written consent will be
enrolled in the study and will receive an exit interview.
CIS data collection
Once CIS's usual service is complete, the information spe-
cialist will ask the customer service questions in the order
listed previously. ECRF will be programmed in such a way
that a zip code which falls within the study area will trig-
ger an electronic prompt for the information specialist to
ask a series of probing questions. The goal of the probing
questions will be to determine if the caller is a part of the
study population and if so, from which clinic and which
study group (Intervention versus Usual Care). The HFO
code will be re-coded to a study code accordingly.
The first probing question is, "Have you or someone you
know recently had an appointment at Prentice Ambula-
tory Clinic or Erie Family Health Center in Chicago? If yes,
which clinic?" If the caller responds "no," then a non-
study HFO code is used and no more probing questions
are asked. If the caller responds either "yes, PAC" or "yes,
Erie" the second probing question is asked.
The second probing question is, "Did you or someone you
know recently receive a call or letter about having a col-
poscopy for a positive pap test?" If the answer is "no,"
then a non-study HFO code is used. If the caller answers,
"yes," then the third probing question is asked.
The third probing question is, "Did your letter or tele-
phone call ask you to call 1-800-4-CANCER?" If the
answer is "no," then the call is coded as either PAC Usual
Care or EFHS Usual Care, depending on the caller's
answer to the first probing question. If the caller answers
"yes," then the call is coded as either PAC Intervention or
EFHS Intervention, depending on the caller's answer in
the first probing question.
Statistical analysis plan
Quality control and data management
Data management and quality control will be the joint
responsibilities of the study coordinator and the labora-
tory data manager, utilizing the resources of the Biostatis-
tics Core Facility of the Robert H. Lurie Comprehensive
Cancer Center. Study databases in Excel and SPSS will be
developed to house all study data. Databases, stored on
the local PCs of the data manager and study coordinator,
will be encrypted and password protected. Entered data
will be monitored and questionable values will be
checked and corrected as appropriate. RandomizationBMC Public Health 2009, 9:444 http://www.biomedcentral.com/1471-2458/9/444
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balance will be evaluated quarterly to assure equal sample
sizes in the study groups.
Statistical analysis
Based on information provided by site providers, we esti-
mate a final N of 500 (250 intervention, 250 control) con-
sented for follow-up to be reasonable and achievable
within the one-year recruitment window. The study has
four specific aims:
Aim 1 is to conduct focus groups about the CIS, and the
targeted study letter with 10 patients and 10 providers
from two large clinics that serve low-income women in
Chicago. Transcripts of the focus groups will be analyzed
qualitatively for content to determine the totality of ideas
that emerge from the discussions. All data will be summa-
rized descriptively. In particular, information will be com-
piled on familiarity with and views about the CIS, barriers
and facilitators to telephoning the CIS for information
about cancer prevention and screening and perceived
information support needs for following up abnormal
Pap tests.
Aim 2 is to randomize and enroll all women between ages
18-60 who receive an abnormal annual Pap test with fol-
low-up scheduling for colposcopy at two clinics for under-
served women. Randomization to Usual Care or
Intervention will be conducted using the previously
described procedure.
Aim 3 is to compare the number of telephone calls made
to the CIS by patients randomized to Intervention versus
Usual Care in order to test the hypothesis that a targeted
physician mailing that asks patients to call the CIS and
suggests questions will increase CIS call volume compared
to Usual Care control. The outcome measure will be
whether or not a study participant calls the CIS. Propor-
tions will be compared between study groups using the
Cochran-Mantel-Haenszel chi-square test [50]. With 250
persons per group, there is 80% power to detect a differ-
ence of a 5% call rate in the control group versus a 12%
call rate in the intervention group. There is greater than
99% power to detect the anticipated difference of 5% in
the control group versus 40% in the intervention group.
Aim 4 is to compare the Intervention and Usual Care
groups' medical follow-up in the 6 months after abnormal
Pap test notification and exit interview data at Pap test fol-
low-up. The two outcome measures will be the dichoto-
mous variable of timely follow-up completion (yes, no) as
well as the CAHPS satisfaction questionnaire. The propor-
tion of participants completing follow-up within 6
months will be compared between study groups using the
Cochran-Mantel-Haenszel chi-square test. It is anticipated
that 450 participants will consent to participation. With
225 persons per group, there is 80% power to detect a dif-
ference between a 55% appropriate follow-up rate in the
control group versus a 68% rate in the intervention group.
There is 99% power to detect the anticipated difference of
55% in the control group versus 75% in the intervention
group.
To compare patient satisfaction between the two groups,
the four-item CAHPS scale will be used where each item is
coded 1 (never, sometimes), 2 (usually) or 3 (always). The
sum of these four items will have a range of 4-12. If this
range represents 4 standard deviation units, then a con-
servatively large estimate of the standard deviation is 2
units on the CAHPS 4-item scale. Anticipated sample size
for the analysis of satisfaction data (given expected fol-
low-up rates of 55% control and 75% intervention) is 293
(control N = 124, intervention N = 169). These sample
sizes have 80% power to detect an effect size of 0.34,
where effect size is defined as the mean difference
between intervention and control, divided by the stand-
ard deviation. With an estimated standard deviation of 2,
this effect size translates into a mean difference of 0.68
(.34 × 2). With these assumptions for the sample size, the
study is powered to detect a consistent difference between
the groups of one response category for one item. Before
the satisfaction data are analyzed, participant characteris-
tics will be compared between the control and interven-
tion subsamples to determine any selection bias that may
have occurred due to differential follow-up between the
groups. Satisfaction data will then be analyzed using a
two-factor analysis of variance, with clinic (EFHC versus
PAC) as one between-subjects factor and study condition
(Usual Care versus Intervention) as the other. The interac-
tion term will determine whether the intervention effect is
different between the two clinics. Any demographic char-
acteristics found to be different between the groups will be
included in this analysis as covariates. Other potential
covariates are whether the physician is patient's usual pro-
vider, language barrier, availability of needed translation,
and whether family members accompany the patient to
the appointment. The intervention by ethnicity (Hispanic
vs. African American) interaction will also be tested: prior
studies neither support nor negate such interaction. For all
power calculations, a two-tailed test and a Type I error rate
of 5% is assumed.
Discussion
The present study will develop and test the efficacy for
enhancing calls to the CIS, timely colposcopy, and satis-
faction with provider-patient communication of a tar-
geted physician mailing. The mailing is designed to
connect the CIS to low-income African-American and His-
panic women who need information about abnormal Pap
tests and colposcopy. The study has the potential to iden-
tify a low-cost, feasible, effective, sustainable, and cultur-BMC Public Health 2009, 9:444 http://www.biomedcentral.com/1471-2458/9/444
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ally sensitive strategy to increase awareness of the CIS and
use of its free cancer information services among an
underserved population. In addition to rigorous efficacy
testing of the intervention during the experimental phase
of the research, the study will examine other aspects of
feasibility such as acceptability, and demand [51]. The
formative phase of the research evaluates the acceptability
of the intervention via focus groups that ask patients and
providers about the design and perceived usefulness of the
proposed targeted physician mailing. Calls to the CIS
from patients participating in the study, a primary out-
come in efficacy testing, also can be interpreted as a meas-
ure of demand for the intervention among the target
population. In this study, demand will be assessed both
by self-reported calls and calls recorded by the CIS.
By testing a feasible intervention in real-life settings of
practice (the clinics) and public service (the CIS), and by
evaluating different aspects of feasibility, the ACCISS
study aims to bridge a gap between research and practice.
So few trials on the efficacy of cancer prevention and con-
trol interventions have been tested under real-world con-
ditions so as to suggest to some that randomized
controlled trials have low applicability to public health
settings [52-54]. The ACCISS study proceeds from the
premise that high quality randomized controlled trials
can be implemented quite feasibly in a real world setting.
Indeed, we suggest that it would be inequitable to test
interventions intended for underserved populations using
research designs less internally valid than those used to
test interventions intended for majority populations.
Patients, providers, and CIS staff all will participate in the
development of the intervention to ensure its acceptabil-
ity, culturally sensitivity, and sustainability. Making dis-
semination potential and practice integration a priority
from the inception of the research, CIS and clinic repre-
sentatives were involved in the development of the pro-
posal for funding. Finally, the inclusion of adherence and
patient satisfaction as primary outcomes is congruent
with recommendations to include multiple, clinically rel-
evant outcomes in practical clinical trials [52,55]. The
research follows these foundational principles so that, if
proven effective, the ACCISS intervention can be sus-
tained and referrals to the CIS can be incorporated into
clinical practice. CIS is well positioned to enhance and
supplement cancer-related information provided in pri-
mary care settings in a manner that benefits both patients
and health care providers. CIS's status as part of the
National Cancer Institute, addresses potential provider
concerns regarding quality of the information provided by
a third party. By offering information in one-on-one inter-
actions with specialists well- trained in the interpersonal
as well as informational aspects of cancer communica-
tion, CIS has potential to invoke trust among underserved
patients who as a rule prefer to receive health information
verbally [14,19].
CIS is also favorably positioned to partner in the complex
endeavor of research. Although it is first and foremost a
service organization, CIS has its own research program
complete with a research agenda dedicated to bridging the
gap between research and service [4]. CIS staff is trained to
conduct research studies embedded in the service environ-
ment. From the perspective of CIS, this study is a model of
collaboration. The research engages CIS with academic
researchers and public health clinics in a mutually benefi-
cial collaboration that strives to produce health benefits
for the underserved.
While the study has considerable strengths, it also has lim-
itations. First, in the clinics and within the CIS, practice/
service takes priority over research. Therefore, extra effort
will be required to integrate research into daily practice
and service activities in a manner that ensures correct
implementation of data collection processes. Second, a
primary outcome, calls to the CIS, will be measured via
patient self-report as well as via calls recorded by CIS as
coming from the study. Because CIS calls are anonymous,
call information cannot be used to verify self-report or
vice versa.
These limitations notwithstanding, the present study has
the potential to connect the CIS to low-income patients
who need cancer screening information. By doing so, the
study may contribute to overcoming communication bar-
riers that underlie cancer health disparities.
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